A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. [electronic resource]
Producer: 20010201Description: 1623-9 p. digitalISSN:- 0007-0920
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- adverse effects
- Cisplatin -- administration & dosage
- Etoposide -- administration & dosage
- Follow-Up Studies
- Humans
- Male
- Neoplasm Metastasis
- Neoplasm Staging
- Neutropenia -- chemically induced
- Seminoma -- drug therapy
- Survival Analysis
- Testicular Neoplasms -- drug therapy
- Thrombocytopenia -- chemically induced
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.